Latest Breaking News On - Io biotech company profile - Page 1 : comparemela.com

IO Biotech (NASDAQ:IOBT) Price Target Raised to $12 00 at HC Wainwright

IO Biotech (NASDAQ:IOBT) Price Target Raised to $12 00 at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Vivo capitalIo biotech incHealth sciencesIo biotech company profileStonepine capital managementSecurities exchange commissionHoldingsas novoArmistice capitalFree reportStock downGet free reportExchange commissionCapital management

Holdings A/S Novo Sells 658,809 Shares of IO Biotech, Inc (NASDAQ:IOBT) Stock

Holdings A/S Novo Sells 658,809 Shares of IO Biotech, Inc (NASDAQ:IOBT) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Venture partners investment advisorIo biotech company profileCitadel advisorsHoldingsas novoIo biotech incMorgan stanleyVivo capitalGet free reportStreet group

Short Interest in IO Biotech, Inc (NASDAQ:IOBT) Drops By 57 2%

IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 116,300 shares, a decrease of 57.2% from the September 15th total of 271,800 shares. Based on an average daily volume of 130,100 shares, the short-interest ratio is currently 0.9 […]

United statesPiper sandlerVivo capital ix llcIo biotech company profileSecurities exchange commissionIo biotech incRenaissance technologiesMorgan stanleyCitadel advisorsAmerica corpGet free reportExchange commissionTrail advisorsIo biotechNasdaq iobt

IO Biotech (NASDAQ:IOBT) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reiterated their buy rating on shares of IO Biotech (NASDAQ:IOBT – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the stock. Separately, Morgan Stanley cut their target price on shares of IO Biotech from $11.00 to $7.00 and set an overweight […]

United statesRenaissance technologiesCitadel advisorsSecurities exchange commissionAmerica corpVivo capital ix llcIo biotech incIo biotech company profileMorgan stanleyFree reportGet free reportExchange commissionTrail advisorsIo biotechNasdaq iobtReiterated rating

IO Biotech, Inc (NASDAQ:IOBT) Sees Significant Decrease in Short Interest

IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 423,200 shares, a drop of 11.1% from the June 15th total of 476,300 shares. Based on an average daily volume of 155,300 shares, […]

United statesAmerica corpIo biotech incRenaissance technologiesIo biotech company profileCitadel advisorsGet free reportStreet groupStock downIo biotechNasdaq iobt